INOVIO Completes Enrollment in the Phase 1 U.S. Trial of INO-4...
PLYMOUTH MEETING, Pennsylvania, April 28, 2020 /PRNewswire-AsiaNet/ -- - INO-4800 Phase 2/3 U.S. clinical trial being prepared to start this summer- Parallel preclinical challenge studies ongoingINOVIO (NASDAQ:INO) today announced that its Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800 is fully...
Authors: LATEST ASIANET NEWS RELEASES